{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T00:02:51Z","timestamp":1793145771613,"version":"4.5.0"},"reference-count":171,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,9]],"date-time":"2024-01-09T00:00:00Z","timestamp":1704758400000},"content-version":"am","delay-in-days":342,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100017219","name":"Schneider-Lesser Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017219","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K08AI20806"],"award-info":[{"award-number":["K08AI20806"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01DA052255"],"award-info":[{"award-number":["R01DA052255"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R21AI152833"],"award-info":[{"award-number":["R21AI152833"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013565","name":"Tennessee Historical Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013565","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","translationalres.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Research"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.trsl.2022.07.008","type":"journal-article","created":{"date-parts":[[2022,7,30]],"date-time":"2022-07-30T21:12:04Z","timestamp":1659215524000},"page":"1-8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"special_numbering":"C","title":["Inflammasomes as mediators of inflammation in HIV-1 infection"],"prefix":"10.1016","volume":"252","author":[{"given":"Alice K.","family":"Min","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trinisia","family":"Fortune","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esha","family":"Hedge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1572-045X","authenticated-orcid":false,"given":"Talia H.","family":"Swartz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"21","key":"10.1016\/j.trsl.2022.07.008_bib0001","article-title":"Pneumocystis Pneumonia -- Los Angeles","volume":"30","year":"1981","journal-title":"MMWR"},{"issue":"4599","key":"10.1016\/j.trsl.2022.07.008_bib0002","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1126\/science.6189183","article-title":"Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS)","volume":"220","author":"Barre-Sinoussi","year":"1983","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.trsl.2022.07.008_bib0003","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1159\/000445852","article-title":"Human immunodeficiency virus (HIV)","volume":"43","year":"2016","journal-title":"Transfus Med Hemother"},{"key":"10.1016\/j.trsl.2022.07.008_bib0004","unstructured":"WHO. HIV data and statistics. 2022 Available at: https:\/\/www.who.int\/teams\/global-hiv-hepatitis-and-stis-programmes\/hiv\/strategic-information\/hiv-data-and-statistics. Accessed 08\/22\/2022."},{"key":"10.1016\/j.trsl.2022.07.008_bib0005","unstructured":"World Health Organization. HIV\/AIDS. 2022. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hiv-aids. Accessed 08\/22\/2022."},{"key":"10.1016\/j.trsl.2022.07.008_bib0006","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3389\/fcvm.2020.00095","article-title":"NLRP3 inflammasome signaling as a link between HIV-1 infection and atherosclerotic cardiovascular disease","volume":"7","author":"Mullis","year":"2020","journal-title":"Front Cardiovasc Med"},{"issue":"3","key":"10.1016\/j.trsl.2022.07.008_bib0007","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1007\/s11904-021-00547-0","article-title":"Probing the interface of HIV and inflammaging","volume":"18","author":"Sieg","year":"2021","journal-title":"Curr HIV\/AIDS Rep"},{"issue":"9635","key":"10.1016\/j.trsl.2022.07.008_bib0008","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0140-6736(08)61113-7","article-title":"Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies","volume":"372","year":"2008","journal-title":"Lancet"},{"issue":"72","key":"10.1016\/j.trsl.2022.07.008_bib0009","first-page":"144","article-title":"Antiretroviral treatment. HIV infection in adults: better-defined first-line treatment","volume":"13","year":"2004","journal-title":"Prescrire Int"},{"issue":"11","key":"10.1016\/j.trsl.2022.07.008_bib0010","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1093\/gerona\/62.11.1279","article-title":"HIV-1 infection is associated with an earlier occurrence of a phenotype related to frailty","volume":"62","author":"Desquilbet","year":"2007","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"6","key":"10.1016\/j.trsl.2022.07.008_bib0011","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.8023","article-title":"What it means to age with HIV infection: years gained are not comorbidity free","volume":"3","author":"Collins","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"3","key":"10.1016\/j.trsl.2022.07.008_bib0012","first-page":"101","article-title":"Aging, inflammation, and HIV infection","volume":"20","author":"Aberg","year":"2012","journal-title":"Top Antivir Med"},{"key":"10.1016\/j.trsl.2022.07.008_bib0013","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1146\/annurev-med-042909-093756","article-title":"HIV infection, inflammation, immunosenescence, and aging","volume":"62","author":"Deeks","year":"2011","journal-title":"Annu Rev Med"},{"issue":"11","key":"10.1016\/j.trsl.2022.07.008_bib0014","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1093\/cid\/cir627","article-title":"Premature age-related comorbidities among HIV-infected persons compared with the general population","volume":"53","author":"Guaraldi","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.trsl.2022.07.008_bib0015","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s11904-010-0041-9","article-title":"HIV and aging: time for a new paradigm","volume":"7","author":"Justice","year":"2010","journal-title":"Curr HIV\/AIDS Rep"},{"issue":"2","key":"10.1016\/j.trsl.2022.07.008_bib0016","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/QAI.0b013e3182745ab0","article-title":"Low-level HIV viremia is associated with microbial translocation and inflammation","volume":"62","author":"Reus","year":"2013","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.trsl.2022.07.008_bib0017","doi-asserted-by":"crossref","first-page":"a3172","DOI":"10.1136\/bmj.a3172","article-title":"HIV infection, antiretroviral treatment, ageing, and non-AIDS related morbidity","volume":"338","author":"Deeks","year":"2009","journal-title":"BMJ"},{"issue":"8","key":"10.1016\/j.trsl.2022.07.008_bib0018","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1093\/infdis\/jir507","article-title":"Immunologic failure despite suppressive antiretroviral therapy is related to activation and turnover of memory CD4 cells","volume":"204","author":"Lederman","year":"2011","journal-title":"J Infect Dis"},{"issue":"7","key":"10.1016\/j.trsl.2022.07.008_bib0019","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1097\/QAD.0b013e328337b957","article-title":"CD4 T-cell hyperactivation and susceptibility to cell death determine poor CD4 T-cell recovery during suppressive HAART","volume":"24","author":"Massanella","year":"2010","journal-title":"AIDS"},{"issue":"2","key":"10.1016\/j.trsl.2022.07.008_bib0020","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1097\/COH.0000000000000230","article-title":"Residual inflammation and viral reservoirs: alliance against an HIV cure","volume":"11","author":"Massanella","year":"2016","journal-title":"Curr Opin HIV AIDS"},{"issue":"10","key":"10.1016\/j.trsl.2022.07.008_bib0021","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1086\/374786","article-title":"T cell activation is associated with lower CD4+ T cell gains in human immunodeficiency virus-infected patients with sustained viral suppression during antiretroviral therapy","volume":"187","author":"Hunt","year":"2003","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.trsl.2022.07.008_bib0022","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/s11904-009-0038-4","article-title":"Early immune senescence in HIV disease","volume":"7","author":"Desai","year":"2010","journal-title":"Curr HIV\/AIDS Rep"},{"issue":"Suppl 2","key":"10.1016\/j.trsl.2022.07.008_bib0023","doi-asserted-by":"crossref","first-page":"S44","DOI":"10.1093\/infdis\/jiw275","article-title":"Immunologic biomarkers, morbidity, and mortality in treated HIV infection","volume":"214","author":"Hunt","year":"2016","journal-title":"J Infect Dis"},{"issue":"3","key":"10.1016\/j.trsl.2022.07.008_bib0024","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.chom.2016.02.012","article-title":"Dissecting how CD4 T cells are lost during HIV infection","volume":"19","author":"Doitsh","year":"2016","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.trsl.2022.07.008_bib0025","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.695674","article-title":"The Hitchhiker guide to CD4(+) T-cell depletion in lentiviral infection. A critical review of the dynamics of the CD4(+) T cells in SIV and HIV infection","volume":"12","author":"Le Hingrat","year":"2021","journal-title":"Front Immunol"},{"issue":"2","key":"10.1016\/j.trsl.2022.07.008_bib0026","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1182\/blood-2003-12-4341","article-title":"HIV-1-specific cytotoxicity is preferentially mediated by a subset of CD8(+) T cells producing both interferon-gamma and tumor necrosis factor-alpha","volume":"104","author":"Lichterfeld","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.trsl.2022.07.008_bib0027","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.3389\/fimmu.2019.01896","article-title":"CD8(+) T-cell response to HIV infection in the era of antiretroviral therapy","volume":"10","author":"Perdomo-Celis","year":"2019","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.trsl.2022.07.008_bib0028","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a007039","article-title":"The antibody response against HIV-1","volume":"2","author":"Overbaugh","year":"2012","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.trsl.2022.07.008_bib0029","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1146\/annurev.immunol.18.1.665","article-title":"Reservoirs for HIV-1: mechanisms for viral persistence in the presence of antiviral immune responses and antiretroviral therapy","volume":"18","author":"Pierson","year":"2000","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.trsl.2022.07.008_bib0030","doi-asserted-by":"crossref","first-page":"585","DOI":"10.3389\/fimmu.2015.00585","article-title":"Purinergic receptors: key mediators of HIV-1 infection and inflammation","volume":"6","author":"Swartz","year":"2015","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.trsl.2022.07.008_bib0031","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1093\/cid\/cis406","article-title":"HIV status, burden of comorbid disease, and biomarkers of inflammation, altered coagulation, and monocyte activation","volume":"55","author":"Armah","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.trsl.2022.07.008_bib0032","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.clim.2006.04.570","article-title":"Low CD4+ T-cell counts in HIV patients receiving effective antiretroviral therapy are associated with CD4+ T-cell activation and senescence but not with lower effector memory T-cell function","volume":"120","author":"Fernandez","year":"2006","journal-title":"Clin Immunol"},{"issue":"23","key":"10.1016\/j.trsl.2022.07.008_bib0033","doi-asserted-by":"crossref","first-page":"9403","DOI":"10.1073\/pnas.0903107106","article-title":"Treatment intensification does not reduce residual HIV-1 viremia in patients on highly active antiretroviral therapy","volume":"106","author":"Dinoso","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.trsl.2022.07.008_bib0034","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1742-6405-11-33","article-title":"Failure of combined antiretroviral therapy intensification with maraviroc and raltegravir in chronically HIV-1 infected patients to reduce the viral reservoir: the IntensHIV randomized trial","volume":"11","author":"Lafeuillade","year":"2014","journal-title":"AIDS Res Ther"},{"issue":"16","key":"10.1016\/j.trsl.2022.07.008_bib0035","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1097\/QAD.0b013e32833ef7bb","article-title":"Effect of raltegravir-containing intensification on HIV burden and T-cell activation in multiple gut sites of HIV-positive adults on suppressive antiretroviral therapy","volume":"24","author":"Yukl","year":"2010","journal-title":"AIDS"},{"issue":"8","key":"10.1016\/j.trsl.2022.07.008_bib0036","doi-asserted-by":"crossref","first-page":"3873","DOI":"10.4049\/jimmunol.1402176","article-title":"The upregulation of LAG-3 on T cells defines a subpopulation with functional exhaustion and correlates with disease progression in HIV-infected subjects","volume":"194","author":"Tian","year":"2015","journal-title":"J Immunol"},{"issue":"7","key":"10.1016\/j.trsl.2022.07.008_bib0037","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005761","article-title":"CD4+ T cells expressing PD-1, TIGIT and LAG-3 contribute to HIV persistence during ART","volume":"12","author":"Fromentin","year":"2016","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.trsl.2022.07.008_bib0038","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.cca.2012.11.025","article-title":"The paradox of the immune response in HIV infection: when inflammation becomes harmful","volume":"416","author":"Ipp","year":"2013","journal-title":"Clin Chim Acta"},{"issue":"5","key":"10.1016\/j.trsl.2022.07.008_bib0039","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.cell.2010.11.001","article-title":"Abortive HIV infection mediates CD4 T cell depletion and inflammation in human lymphoid tissue","volume":"143","author":"Doitsh","year":"2010","journal-title":"Cell"},{"issue":"7484","key":"10.1016\/j.trsl.2022.07.008_bib0040","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/nature12940","article-title":"Cell death by pyroptosis drives CD4 T-cell depletion in HIV-1 infection","volume":"505","author":"Doitsh","year":"2014","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.trsl.2022.07.008_bib0041","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1016\/j.celrep.2015.08.011","article-title":"Cell-to-cell transmission of HIV-1 is required to trigger pyroptotic death of lymphoid-tissue-derived CD4 T cells","volume":"12","author":"Galloway","year":"2015","journal-title":"Cell Rep"},{"issue":"6169","key":"10.1016\/j.trsl.2022.07.008_bib0042","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1126\/science.1243640","article-title":"IFI16 DNA sensor is required for death of lymphoid CD4 T cells abortively infected with HIV","volume":"343","author":"Monroe","year":"2014","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.trsl.2022.07.008_bib0043","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.chom.2015.09.010","article-title":"Blood-derived CD4 T cells naturally resist pyroptosis during abortive HIV-1 infection","volume":"18","author":"Mu\u221a\u00b1oz-Arias","year":"2015","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.trsl.2022.07.008_bib0044","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.657679","article-title":"Gut microbiome homeostasis and the CD4 T- follicular helper cell IgA axis in human immunodeficiency virus infection","volume":"12","author":"Onabajo","year":"2021","journal-title":"Front Immunol"},{"issue":"12","key":"10.1016\/j.trsl.2022.07.008_bib0045","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1038\/nm1511","article-title":"Microbial translocation is a cause of systemic immune activation in chronic HIV infection","volume":"12","author":"Brenchley","year":"2006","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.trsl.2022.07.008_bib0046","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/imr.12065","article-title":"Immune activation and HIV persistence: implications for curative approaches to HIV infection","volume":"254","author":"Klatt","year":"2013","journal-title":"Immunol Rev"},{"issue":"12","key":"10.1016\/j.trsl.2022.07.008_bib0047","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1086\/652749","article-title":"Markers of inflammation, coagulation, and renal function are elevated in adults with HIV infection","volume":"201","author":"Neuhaus","year":"2010","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.trsl.2022.07.008_bib0048","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1093\/cid\/ciw683","article-title":"Persistent, albeit reduced, chronic inflammation in persons starting antiretroviral therapy in acute HIV infection","volume":"64","author":"Sereti","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.trsl.2022.07.008_bib0049","doi-asserted-by":"crossref","first-page":"465","DOI":"10.3389\/fimmu.2019.00465","article-title":"Circulating LPS and (1\u2013>3)-beta-D-Glucan: a Folie a Deux contributing to HIV-associated immune activation","volume":"10","author":"Ramendra","year":"2019","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.trsl.2022.07.008_bib0050","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1136\/gutjnl-2018-317726","article-title":"Increased levels of systemic LPS-positive bacterial extracellular vesicles in patients with intestinal barrier dysfunction","volume":"69","author":"Tulkens","year":"2020","journal-title":"Gut"},{"issue":"3","key":"10.1016\/j.trsl.2022.07.008_bib0051","doi-asserted-by":"crossref","first-page":"148","DOI":"10.2174\/157016211795945296","article-title":"HIV persistence in the gut mucosa of HIV-infected subjects undergoing antiretroviral therapy correlates with immune activation and increased levels of LPS","volume":"9","author":"d'Ettorre","year":"2011","journal-title":"Curr HIV Res"},{"key":"10.1016\/j.trsl.2022.07.008_bib0052","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ebiom.2018.03.024","article-title":"Fecal microbiota composition drives immune activation in HIV-infected individuals","volume":"30","author":"Neff","year":"2018","journal-title":"EBioMedicine"},{"issue":"3","key":"10.1016\/j.trsl.2022.07.008_bib0053","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1097\/COH.0b013e3282f9ae9c","article-title":"The mucosal barrier and immune activation in HIV pathogenesis","volume":"3","author":"Brenchley","year":"2008","journal-title":"Curr Opin HIV AIDS"},{"issue":"12","key":"10.1016\/j.trsl.2022.07.008_bib0054","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006048","article-title":"Microbial translocation and inflammation occur in hyperacute immunodeficiency virus infection and compromise host control of virus replication","volume":"12","author":"Ericsen","year":"2016","journal-title":"PLoS Pathog"},{"issue":"3","key":"10.1016\/j.trsl.2022.07.008_bib0055","doi-asserted-by":"crossref","first-page":"290","DOI":"10.3390\/v12030290","article-title":"Purinergic receptors: elucidating the role of these immune mediators in HIV-1 fusion","volume":"12","author":"Freeman","year":"2020","journal-title":"Viruses"},{"issue":"6","key":"10.1016\/j.trsl.2022.07.008_bib0056","doi-asserted-by":"crossref","first-page":"e01622","DOI":"10.1128\/JVI.01622-19","article-title":"P2X1 selective antagonists block HIV-1 infection through inhibition of envelope conformation-dependent fusion","volume":"94","author":"Soare","year":"2020","journal-title":"J Virol"},{"issue":"19","key":"10.1016\/j.trsl.2022.07.008_bib0057","doi-asserted-by":"crossref","first-page":"11504","DOI":"10.1128\/JVI.01158-14","article-title":"P2X-selective purinergic antagonists are strong inhibitors of HIV-1 fusion during both cell-to-cell and cell-free infection","volume":"88","author":"Swartz","year":"2014","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.trsl.2022.07.008_bib0058","doi-asserted-by":"crossref","first-page":"e00055","DOI":"10.1128\/MMBR.00055-20","article-title":"P2RX7 at the host-pathogen interface of infectious diseases","volume":"85","author":"Soare","year":"2021","journal-title":"Microbiol Mol Biol Rev"},{"issue":"8","key":"10.1016\/j.trsl.2022.07.008_bib0059","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1093\/infdis\/jiu238","article-title":"Gut epithelial barrier dysfunction and innate immune activation predict mortality in treated HIV infection","volume":"210","author":"Hunt","year":"2014","journal-title":"J Infect Dis"},{"issue":"6","key":"10.1016\/j.trsl.2022.07.008_bib0060","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1084\/jem.20040874","article-title":"CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract","volume":"200","author":"Brenchley","year":"2004","journal-title":"J Exp Med"},{"issue":"3","key":"10.1016\/j.trsl.2022.07.008_bib0061","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/ni1316","article-title":"HIV disease: fallout from a mucosal catastrophe?","volume":"7","author":"Brenchley","year":"2006","journal-title":"Nat Immunol"},{"issue":"6","key":"10.1016\/j.trsl.2022.07.008_bib0062","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1084\/jem.20041196","article-title":"Primary HIV-1 infection is associated with preferential depletion of CD4+ T lymphocytes from effector sites in the gastrointestinal tract","volume":"200","author":"Mehandru","year":"2004","journal-title":"J Exp Med"},{"issue":"2","key":"10.1016\/j.trsl.2022.07.008_bib0063","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006202","article-title":"Replication of CMV in the gut of HIV-infected individuals and epithelial barrier dysfunction","volume":"13","author":"Maidji","year":"2017","journal-title":"PLoS Pathog"},{"issue":"3","key":"10.1016\/j.trsl.2022.07.008_bib0064","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0119568","article-title":"Immune activation response in chronic HIV-infected patients: influence of hepatitis C virus coinfection","volume":"10","author":"Marquez","year":"2015","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.trsl.2022.07.008_bib0065","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.3390\/cells9081857","article-title":"Role of inflammasomes in HIV-1 and drug abuse mediated neuroinflammaging","volume":"9","author":"Sil","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.trsl.2022.07.008_bib0066","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2021.135863","article-title":"HIV-1 and drug abuse comorbidity: lessons learned from the animal models of NeuroHIV","volume":"754","author":"Sil","year":"2021","journal-title":"Neurosci Lett"},{"issue":"5","key":"10.1016\/j.trsl.2022.07.008_bib0067","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1080\/09540120802459762","article-title":"HAART receipt and viral suppression among HIV-infected patients with co-occurring mental illness and illicit drug use","volume":"21","author":"Chander","year":"2009","journal-title":"AIDS Care"},{"key":"10.1016\/j.trsl.2022.07.008_bib0068","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/B978-0-444-63849-6.00018-9","article-title":"Imaging studies of the HIV-infected brain","volume":"152","author":"Chang","year":"2018","journal-title":"Handb Clin Neurol"},{"key":"10.1016\/j.trsl.2022.07.008_bib0069","doi-asserted-by":"crossref","first-page":"27864","DOI":"10.1038\/srep27864","article-title":"Effect of cocaine on HIV infection and inflammasome gene expression profile in HIV infected macrophages","volume":"6","author":"Atluri","year":"2016","journal-title":"Sci Rep"},{"issue":"6","key":"10.1016\/j.trsl.2022.07.008_bib0070","first-page":"165","article-title":"Inflammasome in drug abuse","volume":"9","author":"Xu","year":"2017","journal-title":"Int J Physiol Pathophysiol Pharmacol"},{"issue":"13","key":"10.1016\/j.trsl.2022.07.008_bib0071","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1523\/JNEUROSCI.3045-16.2017","article-title":"HIV-1 tat primes and activates microglial NLRP3 inflammasome-mediated neuroinflammation","volume":"37","author":"Chivero","year":"2017","journal-title":"J Neurosci"},{"issue":"2","key":"10.1016\/j.trsl.2022.07.008_bib0072","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s11481-016-9708-3","article-title":"HIV-1 viral protein R activates NLRP3 inflammasome in microglia: implications for HIV-1 associated neuroinflammation","volume":"12","author":"Mamik","year":"2017","journal-title":"J Neuroimmune Pharmacol"},{"key":"10.1016\/j.trsl.2022.07.008_bib0073","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1742-4690-11-35","article-title":"Rapid inflammasome activation in microglia contributes to brain disease in HIV\/AIDS","volume":"11","author":"Walsh","year":"2014","journal-title":"Retrovirology"},{"issue":"5","key":"10.1016\/j.trsl.2022.07.008_bib0074","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s40265-016-0546-7","article-title":"Serious non-AIDS events: therapeutic targets of immune activation and chronic inflammation in HIV infection","volume":"76","author":"Hsu","year":"2016","journal-title":"Drugs"},{"issue":"3","key":"10.1016\/j.trsl.2022.07.008_bib0075","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1097\/QAI.0000000000000468","article-title":"Effect of probiotics (Saccharomyces boulardii) on microbial translocation and inflammation in HIV-treated patients: a double-blind, randomized, placebo-controlled trial","volume":"68","author":"Villar-Garcia","year":"2015","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"9","key":"10.1016\/j.trsl.2022.07.008_bib0076","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1111\/hiv.12046","article-title":"Omega-3 fatty acid therapy reduces triglycerides and interleukin-6 in hypertriglyeridemic HIV patients","volume":"14","author":"Metkus","year":"2013","journal-title":"HIV Med"},{"issue":"2","key":"10.1016\/j.trsl.2022.07.008_bib0077","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S1097-2765(02)00599-3","article-title":"The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta","volume":"10","author":"Martinon","year":"2002","journal-title":"Mol Cell"},{"issue":"7","key":"10.1016\/j.trsl.2022.07.008_bib0078","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/nm.3893","article-title":"Inflammasomes: mechanism of action, role in disease, and therapeutics","volume":"21","author":"Guo","year":"2015","journal-title":"Nat Med"},{"issue":"4","key":"10.1016\/j.trsl.2022.07.008_bib0079","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.cell.2016.03.046","article-title":"Inflammasome complexes: emerging mechanisms and effector functions","volume":"165","author":"Rathinam","year":"2016","journal-title":"Cell"},{"issue":"12","key":"10.1016\/j.trsl.2022.07.008_bib0080","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a016287","article-title":"Inflammasomes","volume":"6","author":"de Zoete","year":"2014","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"1","key":"10.1016\/j.trsl.2022.07.008_bib0081","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/j.1600-065X.2008.00734.x","article-title":"Function of Nod-like receptors in microbial recognition and host defense","volume":"227","author":"Franchi","year":"2009","journal-title":"Immunol Rev"},{"key":"10.1016\/j.trsl.2022.07.008_bib0082","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/s41421-020-0167-x","article-title":"Inflammasome activation and regulation: toward a better understanding of complex mechanisms","volume":"6","author":"Zheng","year":"2020","journal-title":"Cell Discov"},{"issue":"6","key":"10.1016\/j.trsl.2022.07.008_bib0083","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.cell.2010.01.040","article-title":"The inflammasomes","volume":"140","author":"Schroder","year":"2010","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.trsl.2022.07.008_bib0084","doi-asserted-by":"crossref","first-page":"a036392","DOI":"10.1101\/cshperspect.a036392","article-title":"Recent insights on inflammasomes, gasdermin pores, and pyroptosis","volume":"12","author":"de Vasconcelos","year":"2020","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"3","key":"10.1016\/j.trsl.2022.07.008_bib0085","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.immuni.2008.02.005","article-title":"The NLR gene family: a standard nomenclature","volume":"28","author":"Ting","year":"2008","journal-title":"Immunity"},{"issue":"7","key":"10.1016\/j.trsl.2022.07.008_bib0086","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/nri.2016.58","article-title":"Inflammasomes: mechanism of assembly, regulation and signalling","volume":"16","author":"Broz","year":"2016","journal-title":"Nat Rev Immunol"},{"issue":"10","key":"10.1016\/j.trsl.2022.07.008_bib0087","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.1002\/eji.201545523","article-title":"Caspase-4 mediates non-canonical activation of the NLRP3 inflammasome in human myeloid cells","volume":"45","author":"Schmid-Burgk","year":"2015","journal-title":"Eur J Immunol"},{"issue":"19","key":"10.1016\/j.trsl.2022.07.008_bib0088","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25194572","article-title":"ATP-binding and hydrolysis in inflammasome activation","volume":"25","author":"Sandall","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.trsl.2022.07.008_bib0089","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/1487287","article-title":"The role of inflammasome activation in early HIV infection","volume":"2021","author":"Ekabe","year":"2021","journal-title":"J Immunol Res"},{"issue":"4","key":"10.1016\/j.trsl.2022.07.008_bib0090","doi-asserted-by":"crossref","DOI":"10.3390\/v14040666","article-title":"The interplay between viruses and host DNA sensors","volume":"14","author":"Hu\u00e9rfano","year":"2022","journal-title":"Viruses"},{"issue":"6","key":"10.1016\/j.trsl.2022.07.008_bib0091","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.02817-21","article-title":"Toll-like receptor (TLR) signaling enables cyclic GMP-AMP synthase (cGAS) sensing of HIV-1 Infection in macrophages","volume":"12","author":"Siddiqui","year":"2021","journal-title":"mBio"},{"issue":"1","key":"10.1016\/j.trsl.2022.07.008_bib0092","doi-asserted-by":"crossref","first-page":"254","DOI":"10.3390\/cells9010254","article-title":"Sensor sensibility-HIV-1 and the innate immune response","volume":"9","author":"Yin","year":"2020","journal-title":"Cells"},{"issue":"6","key":"10.1016\/j.trsl.2022.07.008_bib0093","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1002\/JLB.3MIR0917-350R","article-title":"An update on cell intrinsic negative regulators of the NLRP3 inflammasome","volume":"103","author":"Poudel","year":"2018","journal-title":"J Leukoc Biol"},{"issue":"11","key":"10.1016\/j.trsl.2022.07.008_bib0094","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.molmed.2019.06.004","article-title":"Self-DNA sensing fuels HIV-1-associated inflammation","volume":"25","author":"Heil","year":"2019","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.trsl.2022.07.008_bib0095","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/bs.ircmb.2018.10.003","article-title":"Nucleic acid sensing in mammals and plants: facts and caveats","volume":"345","author":"Heil","year":"2019","journal-title":"Int Rev Cell Mol Biol"},{"issue":"3","key":"10.1016\/j.trsl.2022.07.008_bib0096","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/ni.1703","article-title":"The inflammasome: a caspase-1-activation platform that regulates immune responses and disease pathogenesis","volume":"10","author":"Franchi","year":"2009","journal-title":"Nat Immunol"},{"issue":"13","key":"10.1016\/j.trsl.2022.07.008_bib0097","doi-asserted-by":"crossref","first-page":"3328","DOI":"10.3390\/ijms20133328","article-title":"The NLRP3 inflammasome: an overview of mechanisms of activation and regulation","volume":"20","author":"Kelley","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.trsl.2022.07.008_bib0098","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3389\/fncel.2017.00063","article-title":"NLRP3 inflammasome in neurological diseases, from functions to therapies","volume":"11","author":"Song","year":"2017","journal-title":"Front Cell Neurosci"},{"issue":"11-12","key":"10.1016\/j.trsl.2022.07.008_bib0099","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1007\/s00018-016-2205-2","article-title":"The intersection of cell death and inflammasome activation","volume":"73","author":"Vince","year":"2016","journal-title":"Cell Mol Life Sci"},{"issue":"7575","key":"10.1016\/j.trsl.2022.07.008_bib0100","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1038\/nature15514","article-title":"Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death","volume":"526","author":"Shi","year":"2015","journal-title":"Nature"},{"issue":"7575","key":"10.1016\/j.trsl.2022.07.008_bib0101","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/nature15541","article-title":"Caspase-11 cleaves gasdermin D for non-canonical inflammasome signalling","volume":"526","author":"Kayagaki","year":"2015","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.trsl.2022.07.008_bib0102","doi-asserted-by":"crossref","first-page":"867","DOI":"10.3390\/vaccines9080867","article-title":"HIV in the brain: identifying viral reservoirs and addressing the challenges of an HIV cure","volume":"9","author":"Ash","year":"2021","journal-title":"Vaccines (Basel)"},{"issue":"2","key":"10.1016\/j.trsl.2022.07.008_bib0103","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/nrn3638","article-title":"Inflammasomes in the CNS","volume":"15","author":"Walsh","year":"2014","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.trsl.2022.07.008_bib0104","doi-asserted-by":"crossref","first-page":"214","DOI":"10.3389\/fimmu.2018.00214","article-title":"The NLRP3 inflammasome is upregulated in HIV-infected antiretroviral therapy-treated individuals with defective immune recovery","volume":"9","author":"Bandera","year":"2018","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.trsl.2022.07.008_bib0105","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1159\/000353902","article-title":"HIV-1 induces the first signal to activate the NLRP3 inflammasome in monocyte-derived macrophages","volume":"57","author":"Hernandez","year":"2014","journal-title":"Intervirology"},{"issue":"2","key":"10.1016\/j.trsl.2022.07.008_bib0106","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/s41419-019-1413-8","article-title":"Recent advances in the mechanisms of NLRP3 inflammasome activation and its inhibitors","volume":"10","author":"Yang","year":"2019","journal-title":"Cell Death Dis"},{"issue":"5","key":"10.1016\/j.trsl.2022.07.008_bib0107","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.molmed.2022.02.010","article-title":"Role of inflammasomes in HIV-1 infection and treatment","volume":"28","author":"Jin","year":"2022","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.trsl.2022.07.008_bib0108","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.molimm.2022.04.018","article-title":"HIV-1 Gag and Vpr impair the inflammasome activation and contribute to the establishment of chronic infection in human primary macrophages","volume":"148","author":"Galv\u00e3o-Lima","year":"2022","journal-title":"Mol Immunol"},{"issue":"2","key":"10.1016\/j.trsl.2022.07.008_bib0109","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s11481-013-9507-z","article-title":"Ligand-gated purinergic receptors regulate HIV-1 tat and morphine related neurotoxicity in primary mouse striatal neuron-glia co-cultures","volume":"9","author":"Sorrell","year":"2014","journal-title":"J Neuroimmun Pharmacol"},{"issue":"4","key":"10.1016\/j.trsl.2022.07.008_bib0110","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1007\/s11481-013-9471-7","article-title":"Adenosine triphosphate released from HIV-infected macrophages regulates glutamatergic tone and dendritic spine density on neurons","volume":"8","author":"Tovar","year":"2013","journal-title":"J Neuroimmun Pharmacol"},{"issue":"9","key":"10.1016\/j.trsl.2022.07.008_bib0111","doi-asserted-by":"crossref","first-page":"4488","DOI":"10.4049\/jimmunol.1102482","article-title":"Purinergic receptors are required for HIV-1 infection of primary human macrophages","volume":"188","author":"Hazleton","year":"2012","journal-title":"J Immunol"},{"issue":"25","key":"10.1016\/j.trsl.2022.07.008_bib0112","doi-asserted-by":"crossref","first-page":"E3265","DOI":"10.1073\/pnas.1500656112","article-title":"Extracellular ATP induces the rapid release of HIV-1 from virus containing compartments of human macrophages","volume":"112","author":"Graziano","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"10.1016\/j.trsl.2022.07.008_bib0113","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1084\/jem.20101805","article-title":"Extracellular ATP acts on P2Y2 purinergic receptors to facilitate HIV-1 infection","volume":"208","author":"Seror","year":"2011","journal-title":"J Exp Med"},{"issue":"2","key":"10.1016\/j.trsl.2022.07.008_bib0114","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1084\/jem.20030648","article-title":"HIV-1 cell to cell transfer across an Env-induced, actin-dependent synapse","volume":"199","author":"Jolly","year":"2004","journal-title":"J Exp Med"},{"issue":"22","key":"10.1016\/j.trsl.2022.07.008_bib0115","doi-asserted-by":"crossref","first-page":"12596","DOI":"10.1128\/JVI.01088-07","article-title":"Sequence of human immunodeficiency virus type 1 (HIV-1) Gag localization and oligomerization monitored with live confocal imaging of a replication-competent, fluorescently tagged HIV-1","volume":"81","author":"Hubner","year":"2007","journal-title":"J Virol"},{"key":"10.1016\/j.trsl.2022.07.008_bib0117","unstructured":"Research Support, U.S. Gov't, Non-P.H.S.) (In English). 2022. DOI: 10.1128\/JVI.01088-07. Sequence of Human Immunodeficiency Virus Type 1 (HIV-1) Gag Localization and Oligomerization Monitored with Live Confocal Imaging of a Replication-Competent, Fluorescently Tagged HIV-1 https:\/\/journals.asm.org\/doi\/10.1128\/JVI.01088-07?cookieSet=1"},{"issue":"3","key":"10.1016\/j.trsl.2022.07.008_bib0118","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1089\/adt.2015.639","article-title":"High-throughput HIV-cell fusion assay for discovery of virus entry inhibitors","volume":"13","author":"Marin","year":"2015","journal-title":"Assay Drug Dev Technol"},{"issue":"18","key":"10.1016\/j.trsl.2022.07.008_bib0119","doi-asserted-by":"crossref","first-page":"9368","DOI":"10.1128\/JVI.01178-15","article-title":"P2X1 receptor antagonists inhibit HIV-1 fusion by blocking virus-coreceptor interactions","volume":"89","author":"Giroud","year":"2015","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.trsl.2022.07.008_bib0120","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01186-18","article-title":"P2X antagonists inhibit HIV-1 productive infection and inflammatory cytokines interleukin-10 (IL-10) and IL-1\u03b2 in a human tonsil explant model","volume":"93","author":"Soare","year":"2019","journal-title":"J Virol"},{"issue":"3","key":"10.1016\/j.trsl.2022.07.008_bib0121","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1189\/jlb.0512249","article-title":"Pannexin1 hemichannels are critical for HIV infection of human primary CD4+ T lymphocytes","volume":"94","author":"Orellana","year":"2013","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.trsl.2022.07.008_bib0122","doi-asserted-by":"crossref","unstructured":"Research Support, Non-U.S. Gov't). 2022. DOI: 10.1189\/jlb.0512249.","DOI":"10.1189\/jlb.0512249"},{"issue":"3","key":"10.1016\/j.trsl.2022.07.008_bib0123","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1189\/jlb.0313148","article-title":"Editorial: pannexin-1\u2014the hidden gatekeeper for HIV-1","volume":"94","author":"Paoletti","year":"2013","journal-title":"J Leukoc Biol"},{"issue":"10","key":"10.1016\/j.trsl.2022.07.008_bib0124","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1016\/j.celrep.2015.08.011","article-title":"Cell-to-cell transmission of HIV-1 is required to trigger pyroptotic death of lymphoid-tissue-derived CD4 T cells","volume":"12","author":"Galloway","year":"2015","journal-title":"Cell Rep"},{"issue":"4","key":"10.1016\/j.trsl.2022.07.008_bib0125","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.chom.2015.09.010","article-title":"Blood-derived CD4 T cells naturally resist pyroptosis during abortive HIV-1 infection","volume":"18","author":"Mu\u00f1oz-Arias","year":"2015","journal-title":"Cell Host Microbe"},{"issue":"2","key":"10.1016\/j.trsl.2022.07.008_bib0126","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1128\/JVI.02297-15","article-title":"Next-generation mRNA sequencing reveals pyroptosis-induced CD4+ T cell death in early simian immunodeficiency virus-infected lymphoid tissues","volume":"90","author":"Lu","year":"2016","journal-title":"J Virol"},{"issue":"6","key":"10.1016\/j.trsl.2022.07.008_bib0127","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1111\/iji.12157","article-title":"Polymorphism in IFI16 affects CD4(+) T-cell counts in HIV-1 infection","volume":"41","author":"Booiman","year":"2014","journal-title":"Int J Immunogenet"},{"issue":"1","key":"10.1016\/j.trsl.2022.07.008_bib0128","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/cei.12317","article-title":"Innate DNA sensing is impaired in HIV patients and IFI16 expression correlates with chronic immune activation","volume":"177","author":"Nissen","year":"2014","journal-title":"Clin Exp Immunol"},{"issue":"2","key":"10.1016\/j.trsl.2022.07.008_bib0129","first-page":"95","article-title":"Restriction factors expression decreases in HIV-1 patients after cART","volume":"44","author":"D'Urbano","year":"2021","journal-title":"New Microbiol"},{"issue":"48","key":"10.1016\/j.trsl.2022.07.008_bib0130","doi-asserted-by":"crossref","first-page":"E4571","DOI":"10.1073\/pnas.1311669110","article-title":"IFI16 senses DNA forms of the lentiviral replication cycle and controls HIV-1 replication","volume":"110","author":"Jakobsen","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"10.1016\/j.trsl.2022.07.008_bib0131","doi-asserted-by":"crossref","DOI":"10.3390\/v12050495","article-title":"Cellular factors targeting HIV-1 transcription and Viral RNA transcripts","volume":"12","author":"Nchioua","year":"2020","journal-title":"Viruses"},{"issue":"1","key":"10.1016\/j.trsl.2022.07.008_bib0132","doi-asserted-by":"crossref","DOI":"10.1016\/j.xpro.2020.100236","article-title":"IFI16 knockdown in primary HIV-1 target cells","volume":"2","author":"Bosso","year":"2021","journal-title":"STAR Protoc"},{"issue":"8","key":"10.1016\/j.trsl.2022.07.008_bib0133","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1008752","article-title":"Nuclear PYHIN proteins target the host transcription factor Sp1 thereby restricting HIV-1 in human macrophages and CD4+ T cells","volume":"16","author":"Bosso","year":"2020","journal-title":"PLoS Pathog"},{"issue":"6","key":"10.1016\/j.trsl.2022.07.008_bib0134","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/j.chom.2019.05.002","article-title":"IFI16 targets the transcription factor Sp1 to suppress HIV-1 transcription and latency reactivation","volume":"25","author":"Hotter","year":"2019","journal-title":"Cell Host Microbe"},{"issue":"2","key":"10.1016\/j.trsl.2022.07.008_bib0135","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/QAI.0b013e31828f93bb","article-title":"Susceptibility to Mycobacterium tuberculosis infection in HIV-positive patients is associated with CARD8 genetic variant","volume":"63","author":"Pontillo","year":"2013","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"2","key":"10.1016\/j.trsl.2022.07.008_bib0136","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1097\/QAI.0b013e3182392ebe","article-title":"Polymorphisms in inflammasome' genes and susceptibility to HIV-1 infection","volume":"59","author":"Pontillo","year":"2012","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"6535","key":"10.1016\/j.trsl.2022.07.008_bib0137","doi-asserted-by":"crossref","DOI":"10.1126\/science.abe1707","article-title":"CARD8 is an inflammasome sensor for HIV-1 protease activity","volume":"371","author":"Wang","year":"2021","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.trsl.2022.07.008_bib0138","doi-asserted-by":"crossref","DOI":"10.3390\/v14061179","article-title":"Beyond inhibition: a novel strategy of targeting HIV-1 protease to eliminate viral reservoirs","volume":"14","author":"Kim","year":"2022","journal-title":"Viruses"},{"issue":"4","key":"10.1016\/j.trsl.2022.07.008_bib0139","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0192845","article-title":"HIV replication is associated to inflammasomes activation, IL-1\u03b2, IL-18 and caspase-1 expression in GALT and peripheral blood","volume":"13","author":"Feria","year":"2018","journal-title":"PLoS One"},{"issue":"6528","key":"10.1016\/j.trsl.2022.07.008_bib0140","doi-asserted-by":"crossref","DOI":"10.1126\/science.abd0811","article-title":"Human NLRP1 is a sensor for double-stranded RNA","volume":"371","author":"Bauernfried","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.trsl.2022.07.008_bib0141","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2021.756471","article-title":"Landscape of T cells transcriptional and metabolic modules during HIV infection based on weighted gene co-expression network analysis","volume":"12","author":"Xu","year":"2021","journal-title":"Front Genet"},{"key":"10.1016\/j.trsl.2022.07.008_bib0142","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.3389\/fimmu.2019.01291","article-title":"Flagellin\/NLRC4 pathway rescues NLRP3-inflammasome defect in dendritic cells from HIV-infected patients: perspective for new adjuvant in immunocompromised individuals","volume":"10","author":"Dos Reis","year":"2019","journal-title":"Front Immunol"},{"issue":"4","key":"10.1016\/j.trsl.2022.07.008_bib0143","doi-asserted-by":"crossref","first-page":"415","DOI":"10.3390\/vaccines1040415","article-title":"DNA-encoded flagellin activates toll-like receptor 5 (TLR5), Nod-like receptor family CARD domain-containing protein 4 (NRLC4), and acts as an epidermal, systemic, and mucosal-adjuvant","volume":"1","author":"Nystr\u00f6m","year":"2013","journal-title":"Vaccines (Basel)"},{"issue":"4","key":"10.1016\/j.trsl.2022.07.008_bib0144","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1093\/cid\/ciz898","article-title":"A common NLRC4 gene variant associates with inflammation and pulmonary function in human immunodeficiency virus and tuberculosis","volume":"71","author":"Ravimohan","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.trsl.2022.07.008_bib0145","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1009417","article-title":"Differential recognition of HIV-stimulated IL-1\u03b2 and IL-18 secretion through NLR and NAIP signalling in monocyte-derived macrophages","volume":"17","author":"Triantafilou","year":"2021","journal-title":"PLoS Pathog"},{"issue":"32","key":"10.1016\/j.trsl.2022.07.008_bib0146","doi-asserted-by":"crossref","first-page":"E4671","DOI":"10.1073\/pnas.1602419113","article-title":"AIM2 inflammasome is activated by pharmacological disruption of nuclear envelope integrity","volume":"113","author":"Di Micco","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.trsl.2022.07.008_bib0147","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.3389\/fimmu.2019.02538","article-title":"Pharmacological inhibitors of the NLRP3 inflammasome","volume":"10","author":"Zahid","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.trsl.2022.07.008_bib0148","doi-asserted-by":"crossref","first-page":"262","DOI":"10.3389\/fphar.2015.00262","article-title":"NLRP3 inflammasome and its inhibitors: a review","volume":"6","author":"Shao","year":"2015","journal-title":"Front Pharmacol"},{"issue":"3","key":"10.1016\/j.trsl.2022.07.008_bib0149","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nm.3806","article-title":"A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases","volume":"21","author":"Coll","year":"2015","journal-title":"Nat Med"},{"issue":"2","key":"10.1016\/j.trsl.2022.07.008_bib0150","doi-asserted-by":"crossref","first-page":"974","DOI":"10.4049\/jimmunol.0904145","article-title":"NLRP3 plays a critical role in the development of experimental autoimmune encephalomyelitis by mediating Th1 and Th17 responses","volume":"185","author":"Gris","year":"2010","journal-title":"J Immunol"},{"issue":"11","key":"10.1016\/j.trsl.2022.07.008_bib0151","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1084\/jem.20171419","article-title":"Identification of a selective and direct NLRP3 inhibitor to treat inflammatory disorders","volume":"214","author":"Jiang","year":"2017","journal-title":"J Exp Med"},{"issue":"2","key":"10.1016\/j.trsl.2022.07.008_bib0152","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1074\/jbc.M113.515080","article-title":"3,4-methylenedioxy-\u03b2-nitrostyrene inhibits NLRP3 inflammasome activation by blocking assembly of the inflammasome","volume":"289","author":"He","year":"2014","journal-title":"J Biol Chem"},{"issue":"7","key":"10.1016\/j.trsl.2022.07.008_bib0153","doi-asserted-by":"crossref","first-page":"E1530","DOI":"10.1073\/pnas.1716095115","article-title":"OLT1177, a beta-sulfonyl nitrile compound, safe in humans, inhibits the NLRP3 inflammasome and reverses the metabolic cost of inflammation","volume":"115","author":"Marchetti","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"10.1016\/j.trsl.2022.07.008_bib0154","doi-asserted-by":"crossref","first-page":"e8689","DOI":"10.15252\/emmm.201708689","article-title":"Tranilast directly targets NLRP3 to treat inflammasome-driven diseases","volume":"10","author":"Huang","year":"2018","journal-title":"EMBO Mol Med"},{"issue":"1","key":"10.1016\/j.trsl.2022.07.008_bib0155","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1038\/s41467-018-04947-6","article-title":"Oridonin is a covalent NLRP3 inhibitor with strong anti-inflammasome activity","volume":"9","author":"He","year":"2018","journal-title":"Nat Commun"},{"issue":"8","key":"10.1016\/j.trsl.2022.07.008_bib0156","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1172\/JCI25495","article-title":"ATP-sensitive potassium channelopathies: focus on insulin secretion","volume":"115","author":"Ashcroft","year":"2005","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.trsl.2022.07.008_bib0157","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1083\/jcb.200903124","article-title":"Glyburide inhibits the cryopyrin\/Nalp3 inflammasome","volume":"187","author":"Lamkanfi","year":"2009","journal-title":"J Cell Biol"},{"issue":"10","key":"10.1016\/j.trsl.2022.07.008_bib0158","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1016\/j.bcp.2013.03.008","article-title":"A novel benzo[d]imidazole derivate prevents the development of dextran sulfate sodium-induced murine experimental colitis via inhibition of NLRP3 inflammasome","volume":"85","author":"Liu","year":"2013","journal-title":"Biochem Pharmacol"},{"issue":"10","key":"10.1016\/j.trsl.2022.07.008_bib0159","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1016\/j.amjcard.2013.01.287","article-title":"Effects of interleukin-1 blockade with anakinra on adverse cardiac remodeling and heart failure after acute myocardial infarction [from the Virginia Commonwealth University-Anakinra Remodeling Trial (2) (VCU-ART2) pilot study]","volume":"111","author":"Abbate","year":"2013","journal-title":"Am J Cardiol"},{"issue":"4","key":"10.1016\/j.trsl.2022.07.008_bib0160","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1093\/eurjhf\/hfq017","article-title":"Interleukin-1beta modulation using a genetically engineered antibody prevents adverse cardiac remodelling following acute myocardial infarction in the mouse","volume":"12","author":"Abbate","year":"2010","journal-title":"Eur J Heart Fail"},{"issue":"1","key":"10.1016\/j.trsl.2022.07.008_bib0161","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s00395-017-0663-9","article-title":"Role of NLRP3 inflammasome in the pathogenesis of cardiovascular diseases","volume":"113","author":"Liu","year":"2017","journal-title":"Basic Res Cardiol"},{"issue":"12","key":"10.1016\/j.trsl.2022.07.008_bib0162","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N Engl J Med"},{"issue":"23","key":"10.1016\/j.trsl.2022.07.008_bib0163","doi-asserted-by":"crossref","first-page":"4449","DOI":"10.1007\/s00018-016-2300-4","article-title":"The CB2 receptor and its role as a regulator of inflammation","volume":"73","author":"Turcotte","year":"2016","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.trsl.2022.07.008_bib0164","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-3-030-21737-2_1","article-title":"Endocannabinoid system components: overview and tissue distribution","volume":"1162","author":"Joshi","year":"2019","journal-title":"Adv Exp Med Biol"},{"issue":"3","key":"10.1016\/j.trsl.2022.07.008_bib0165","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1007\/s10753-018-0945-x","article-title":"Selective activation of cannabinoid receptor 2 attenuates myocardial infarction via suppressing NLRP3 inflammasome","volume":"42","author":"Yu","year":"2019","journal-title":"Inflammation"},{"issue":"9","key":"10.1016\/j.trsl.2022.07.008_bib0166","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0155076","article-title":"Activation of cannabinoid receptor 2 ameliorates DSS-induced colitis through inhibiting NLRP3 inflammasome in macrophages","volume":"11","author":"Ke","year":"2016","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.trsl.2022.07.008_bib0167","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s12974-017-0913-7","article-title":"Activation of cannabinoid receptor type 2 attenuates surgery-induced cognitive impairment in mice through anti-inflammatory activity","volume":"14","author":"Sun","year":"2017","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.trsl.2022.07.008_bib0168","doi-asserted-by":"crossref","first-page":"559","DOI":"10.3389\/fphys.2016.00559","article-title":"Cannabidiol modulates the immunophenotype and inhibits the activation of the inflammasome in human gingival mesenchymal stem cells","volume":"7","author":"Libro","year":"2016","journal-title":"Front Physiol"},{"issue":"3","key":"10.1016\/j.trsl.2022.07.008_bib0169","doi-asserted-by":"crossref","first-page":"e33961","DOI":"10.1371\/journal.pone.0033961","article-title":"Cannabinoid receptor 2-mediated attenuation of CXCR4-tropic HIV infection in primary CD4+ T cells","volume":"7","author":"Costantino","year":"2012","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.trsl.2022.07.008_bib0170","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/QAI.0b013e3181967354","article-title":"Probable deceleration of progression of Simian AIDS affected by opiate dependency: studies with a rhesus macaque\/SIVsmm9 model","volume":"50","author":"Donahoe","year":"2009","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"1","key":"10.1016\/j.trsl.2022.07.008_bib0171","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1124\/jpet.109.163055","article-title":"Cannabinoid inhibition of macrophage migration to the trans-activating (Tat) protein of HIV-1 is linked to the CB(2) cannabinoid receptor","volume":"333","author":"Raborn","year":"2010","journal-title":"J Pharmacol Exp Ther"},{"issue":"15","key":"10.1016\/j.trsl.2022.07.008_bib0172","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1097\/QAD.0000000000002345","article-title":"Cannabinoids and inflammation: implications for people living with HIV","volume":"33","author":"Costiniuk","year":"2019","journal-title":"AIDS"}],"container-title":["Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931524422001736?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931524422001736?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T12:48:08Z","timestamp":1761828488000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1931524422001736"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":171,"alternative-id":["S1931524422001736"],"URL":"https:\/\/doi.org\/10.1016\/j.trsl.2022.07.008","relation":{},"ISSN":["1931-5244"],"issn-type":[{"value":"1931-5244","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inflammasomes as mediators of inflammation in HIV-1 infection","name":"articletitle","label":"Article Title"},{"value":"Translational Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trsl.2022.07.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}